Cargando…

F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects

E3 ubiquitin ligases play a critical role in cellular mechanisms and cancer progression. F-box protein is the core component of the SKP1-cullin 1-F-box (SCF)-type E3 ubiquitin ligase and directly binds to substrates by various specific domains. According to the specific domains, F-box proteins are f...

Descripción completa

Detalles Bibliográficos
Autores principales: Tekcham, Dinesh Singh, Chen, Di, Liu, Yu, Ling, Ting, Zhang, Yi, Chen, Huan, Wang, Wen, Otkur, Wuxiyar, Qi, Huan, Xia, Tian, Liu, Xiaolong, Piao, Hai-long, Liu, Hongxu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086354/
https://www.ncbi.nlm.nih.gov/pubmed/32226545
http://dx.doi.org/10.7150/thno.42735
_version_ 1783509110009888768
author Tekcham, Dinesh Singh
Chen, Di
Liu, Yu
Ling, Ting
Zhang, Yi
Chen, Huan
Wang, Wen
Otkur, Wuxiyar
Qi, Huan
Xia, Tian
Liu, Xiaolong
Piao, Hai-long
Liu, Hongxu
author_facet Tekcham, Dinesh Singh
Chen, Di
Liu, Yu
Ling, Ting
Zhang, Yi
Chen, Huan
Wang, Wen
Otkur, Wuxiyar
Qi, Huan
Xia, Tian
Liu, Xiaolong
Piao, Hai-long
Liu, Hongxu
author_sort Tekcham, Dinesh Singh
collection PubMed
description E3 ubiquitin ligases play a critical role in cellular mechanisms and cancer progression. F-box protein is the core component of the SKP1-cullin 1-F-box (SCF)-type E3 ubiquitin ligase and directly binds to substrates by various specific domains. According to the specific domains, F-box proteins are further classified into three sub-families: 1) F-box with leucine rich amino acid repeats (FBXL); 2) F-box with WD 40 amino acid repeats (FBXW); 3) F-box only with uncharacterized domains (FBXO). Here, we summarize the substrates of F-box proteins, discuss the important molecular mechanism and emerging role of F-box proteins especially from the perspective of cancer development and progression. These findings will shed new light on malignant tumor progression mechanisms, and suggest the potential role of F-box proteins as cancer biomarkers and therapeutic targets for future cancer treatment.
format Online
Article
Text
id pubmed-7086354
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-70863542020-03-27 F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects Tekcham, Dinesh Singh Chen, Di Liu, Yu Ling, Ting Zhang, Yi Chen, Huan Wang, Wen Otkur, Wuxiyar Qi, Huan Xia, Tian Liu, Xiaolong Piao, Hai-long Liu, Hongxu Theranostics Review E3 ubiquitin ligases play a critical role in cellular mechanisms and cancer progression. F-box protein is the core component of the SKP1-cullin 1-F-box (SCF)-type E3 ubiquitin ligase and directly binds to substrates by various specific domains. According to the specific domains, F-box proteins are further classified into three sub-families: 1) F-box with leucine rich amino acid repeats (FBXL); 2) F-box with WD 40 amino acid repeats (FBXW); 3) F-box only with uncharacterized domains (FBXO). Here, we summarize the substrates of F-box proteins, discuss the important molecular mechanism and emerging role of F-box proteins especially from the perspective of cancer development and progression. These findings will shed new light on malignant tumor progression mechanisms, and suggest the potential role of F-box proteins as cancer biomarkers and therapeutic targets for future cancer treatment. Ivyspring International Publisher 2020-03-04 /pmc/articles/PMC7086354/ /pubmed/32226545 http://dx.doi.org/10.7150/thno.42735 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Review
Tekcham, Dinesh Singh
Chen, Di
Liu, Yu
Ling, Ting
Zhang, Yi
Chen, Huan
Wang, Wen
Otkur, Wuxiyar
Qi, Huan
Xia, Tian
Liu, Xiaolong
Piao, Hai-long
Liu, Hongxu
F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects
title F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects
title_full F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects
title_fullStr F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects
title_full_unstemmed F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects
title_short F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects
title_sort f-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086354/
https://www.ncbi.nlm.nih.gov/pubmed/32226545
http://dx.doi.org/10.7150/thno.42735
work_keys_str_mv AT tekchamdineshsingh fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects
AT chendi fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects
AT liuyu fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects
AT lingting fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects
AT zhangyi fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects
AT chenhuan fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects
AT wangwen fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects
AT otkurwuxiyar fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects
AT qihuan fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects
AT xiatian fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects
AT liuxiaolong fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects
AT piaohailong fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects
AT liuhongxu fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects